[go: up one dir, main page]

NO20002371D0 - 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom - Google Patents

2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom

Info

Publication number
NO20002371D0
NO20002371D0 NO20002371A NO20002371A NO20002371D0 NO 20002371 D0 NO20002371 D0 NO 20002371D0 NO 20002371 A NO20002371 A NO 20002371A NO 20002371 A NO20002371 A NO 20002371A NO 20002371 D0 NO20002371 D0 NO 20002371D0
Authority
NO
Norway
Prior art keywords
arylbenzo
thiophenes
treatment
estrogen deprivation
deprivation syndrome
Prior art date
Application number
NO20002371A
Other languages
English (en)
Other versions
NO20002371L (no
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20002371D0 publication Critical patent/NO20002371D0/no
Publication of NO20002371L publication Critical patent/NO20002371L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO20002371A 1997-11-14 2000-05-05 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom NO20002371L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6585497P 1997-11-14 1997-11-14
PCT/US1998/023719 WO1999025707A1 (en) 1997-11-14 1998-11-09 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME

Publications (2)

Publication Number Publication Date
NO20002371D0 true NO20002371D0 (no) 2000-05-05
NO20002371L NO20002371L (no) 2000-07-05

Family

ID=22065580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002371A NO20002371L (no) 1997-11-14 2000-05-05 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom

Country Status (20)

Country Link
US (2) US6096781A (no)
EP (1) EP0920862A1 (no)
JP (1) JP2001523676A (no)
KR (1) KR20010031903A (no)
CN (1) CN1109683C (no)
AU (1) AU748395B2 (no)
BR (1) BR9813996A (no)
CA (1) CA2309859A1 (no)
EA (1) EA003471B1 (no)
HR (1) HRP20000288A2 (no)
HU (1) HUP0004731A3 (no)
ID (1) ID26865A (no)
IL (1) IL135511A0 (no)
NO (1) NO20002371L (no)
NZ (1) NZ503988A (no)
PL (1) PL340431A1 (no)
TR (1) TR200001288T2 (no)
TW (1) TW467909B (no)
WO (1) WO1999025707A1 (no)
ZA (1) ZA9810214B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6258826B1 (en) 1998-10-13 2001-07-10 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
DE19913349A1 (de) * 1999-03-24 2000-09-28 Clariant Gmbh Benzothiophene und ihre Verwendung in flüssigkristallinen Mischungen
WO2003069980A2 (en) * 2002-02-20 2003-08-28 J.R. Simplot Company Precise breeding
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
US20060194869A1 (en) * 2004-12-23 2006-08-31 Santiago Ini Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
CA2928173C (en) * 2012-10-24 2021-10-19 The Board Of Trustees Of The University Of Illinois Compositions comprising benzothiophene derivatives and use thereof for treatment of estrogen-related medical disorders
EP2912033A4 (en) 2012-10-24 2016-09-14 Univ Illinois COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES
CN107325067B (zh) * 2017-05-03 2020-05-12 广州中医药大学 磷酸二酯酶4抑制剂桑辛素m衍生物及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4588484A (en) * 1985-02-28 1986-05-13 Eli Lilly And Company Electrochemical reduction of 3-chlorobenzo[b]thiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US5389670A (en) * 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
US5811120A (en) * 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US5972383A (en) * 1994-03-02 1999-10-26 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
JP3989569B2 (ja) * 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー ベンゾチオフェン化合物、中間体、組成物および方法
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
US5514703A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophene compounds useful for inhibiting lipoxygenase
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
ATE198477T1 (de) * 1995-06-26 2001-01-15 Lilly Co Eli Benzothiophenderivate
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN

Also Published As

Publication number Publication date
WO1999025707A1 (en) 1999-05-27
EA003471B1 (ru) 2003-06-26
EA200000519A1 (ru) 2000-10-30
EP0920862A1 (en) 1999-06-09
HUP0004731A2 (hu) 2001-08-28
NZ503988A (en) 2001-09-28
JP2001523676A (ja) 2001-11-27
US6096781A (en) 2000-08-01
HUP0004731A3 (en) 2003-01-28
ZA9810214B (en) 2000-05-09
TW467909B (en) 2001-12-11
IL135511A0 (en) 2001-05-20
CA2309859A1 (en) 1999-05-27
NO20002371L (no) 2000-07-05
BR9813996A (pt) 2000-09-26
TR200001288T2 (tr) 2000-09-21
CN1278811A (zh) 2001-01-03
AU1386199A (en) 1999-06-07
AU748395B2 (en) 2002-06-06
ID26865A (id) 2001-02-15
US6395769B1 (en) 2002-05-28
KR20010031903A (ko) 2001-04-16
PL340431A1 (en) 2001-02-12
HRP20000288A2 (en) 2000-08-31
CN1109683C (zh) 2003-05-28

Similar Documents

Publication Publication Date Title
NO20011936L (no) Fremgangsmate for fremstilling av citalopram
NO980707D0 (no) Fremgangsmåte til fremstilling av kopolymerer
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
NO20015017L (no) Fremgangsmate for fremstilling av citalopram
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO20010318L (no) Fremgangsmåte for fremstilling av Citalopram
NO20010319L (no) Fremgangsmate for fremstilling av Citalopram
NO20002371D0 (no) 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO301621B1 (no) Vikleranordning for fôrballer
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO980306D0 (no) Fremgangsmåte for applisering av skje
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
NO20011268D0 (no) Forbindelse til behandling av depresjon
NO991104D0 (no) FremgangsmÕte for fremstilling av sausbasis
FI963415A0 (fi) Packning av hushaollsvaetskekartonger och -toravfall
NO20002267L (no) FremgangsmÕte ved fremstilling av citalopram

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application